Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML

Clinical trial NCT04887259 · TERMINATED

Trial details

NCT number: NCT04887259
Sponsor: Lava Therapeutics
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia Multiple Myeloma Acute Myeloid Leukemia

Start date: 2021-07-12
Primary completion: 2023-09-06
Enrollment: 16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.